Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral med...
Leadership
Christopher M. Starr Ph.D.Founder
Co-Founder & Independent Executive Chairman of the Board
Chandler D. Robinson M.B.A., M.D., M.Sc.Founder
Co-Founder, CEO, President & Director
Quan Anh Vu
CFO, Principal accounting officer, Principal financial officer, Secretary & Treasurer
